122 related articles for article (PubMed ID: 793175)
1. [Elaboration of objective methods of clinical evaluation of new antirheumatic drugs].
Sigidin IaA; Tsvetkova ES
Vopr Revm; 1976; (3):18-23. PubMed ID: 793175
[No Abstract] [Full Text] [Related]
2. Panel discussion on clinical trials: parameter reliability.
Rasmussen GG
Rheumatol Rehabil; 1978; Suppl():128-31. PubMed ID: 364604
[No Abstract] [Full Text] [Related]
3. From computer modeling to FDA approval: research strategy for the discovery of new anti-arthritic drugs.
Ackerman NR
Del Med J; 1988 Nov; 60(11):665-6. PubMed ID: 3068079
[No Abstract] [Full Text] [Related]
4. New drugs for rheumatoid arthritis.
Med Lett Drugs Ther; 1998 Nov; 40(1040):110-2. PubMed ID: 9844625
[No Abstract] [Full Text] [Related]
5. [New basic preparations with prolonged action in the treatment of rheumatoid arthritis].
Tumanova IG; Sigidin IaA
Ter Arkh; 1987; 59(4):80-3. PubMed ID: 2884735
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study with isonixine].
Asensi E; Barceló P
Rev Esp Reum Enferm Osteoartic; 1977; 20(2):159-67. PubMed ID: 327518
[No Abstract] [Full Text] [Related]
7. [Long-term drug treatment of chronic polyarthritis: current status and perspectives].
Wollenhaupt J; Langer HE
Wien Med Wochenschr; 1990 Jun; 140(12):324-33. PubMed ID: 2204217
[TBL] [Abstract][Full Text] [Related]
8. ACR 20: clinical or statistical significance?
Pincus T; Stein CM
Arthritis Rheum; 1999 Aug; 42(8):1572-6. PubMed ID: 10446853
[No Abstract] [Full Text] [Related]
9. Inhibitors of tumor necrosis factor for rheumatoid arthritis.
Moreland LW
J Rheumatol Suppl; 1999 May; 57():7-15. PubMed ID: 10328137
[TBL] [Abstract][Full Text] [Related]
10. [A clinical evaluation of CN-100 in patients with rheumatoid arthritis].
Yoshizawa H; Ogawa N; Azuma T
Ryumachi; 1991 Feb; 31(1):127-38. PubMed ID: 1857991
[No Abstract] [Full Text] [Related]
11. Drugs for rheumatoid arthritis.
Treat Guidel Med Lett; 2009 May; 7(81):37-46; quiz 47-8. PubMed ID: 19390497
[No Abstract] [Full Text] [Related]
12. Drugs for rheumatoid arthritis.
Treat Guidel Med Lett; 2005 Dec; 3(40):83-90. PubMed ID: 16299450
[No Abstract] [Full Text] [Related]
13. [Drug treatment of rheumatoid arthritis and osteoarthritis].
Trnavský K; Pavelka K
Z Gesamte Inn Med; 1987 Aug; 42(15):434-6. PubMed ID: 2890243
[TBL] [Abstract][Full Text] [Related]
14. Methodology issues in the evaluation of NSAID in inflammatory rheumatic diseases.
Lequesne M
J Rheumatol Suppl; 1990 Feb; 20():25-8. PubMed ID: 2182853
[TBL] [Abstract][Full Text] [Related]
15. [An evaluation of the results of the long-term treatment of rheumatoid arthritis patients with gold salts, aminoquinoline preparations and nonsteroidal anti-inflammatory preparations].
Ivanova MM; Karateev DE; Shakirova MR; Smirnov AV
Ter Arkh; 1997; 69(5):27-32. PubMed ID: 9235650
[No Abstract] [Full Text] [Related]
16. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
Ranganath VK; Furst DE
Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of proglumetacin malate in rheumatoid arthritis--a multi-institutional cooperative study].
Ryumachi; 1986 Oct; 26(5):377-88. PubMed ID: 3299753
[No Abstract] [Full Text] [Related]
18. [Non-steroidal anti-inflammatory therapy in rheumatology].
Sigidin IaA
Ter Arkh; 1986; 58(7):3-8. PubMed ID: 3764738
[No Abstract] [Full Text] [Related]
19. [The role of disease-modifying antirheumatic drugs (DMARDs) in the therapy of rheumatoid arthritis].
Cervini C; Salaffi F; Peroni M
Clin Ter; 1993 Jan; 142(1):3-18. PubMed ID: 8472508
[TBL] [Abstract][Full Text] [Related]
20. New directions in rheumatoid arthritis.
Cornell S
Adv Nurse Pract; 1997 Mar; 5(3):61-4. PubMed ID: 9459884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
